Press Releases July 29, 2026 09:00 AM

Natural Health Trends Reports Second Quarter 2026 Financial Results

Natural Health Trends Reports Q2 2026 Results with Revenue and Earnings Decline Amid Challenging Environment

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
NHTC

Natural Health Trends Corp. announced a 23% revenue decline and increased net loss in Q2 2026 due to challenging market conditions and regulatory uncertainties affecting its direct-selling and e-commerce business across Asia, the Americas, and Europe. The company authorized stock repurchases and highlighted cost savings from restructuring efforts, while preparing for its 25th anniversary in Hong Kong.

Natural Health Trends Reports Second Quarter 2026 Financial Results
NHTC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Q2 2026 revenue decreased 23% to $7.6 million compared to Q2 2025, with net loss increasing to $451,000.
  • Restructuring program has generated over $600,000 in cost savings year-to-date and continues to streamline operations.
  • Resumption of stock repurchases authorized with nearly $16 million available, signaling confidence in long-term value.

– Company preparing for its 25th anniversary celebration in Hong Kong in the next quarter
– Board of Directors authorized resuming stock repurchases, with approximately $16 million available  
– Restructuring program generated approximately $300,000 of operating and other margin-related cost savings during the quarter
– Year-to-date savings from the restructuring program have exceeded $600,000

LOS ANGELES, July 29, 2026 (GLOBE NEWSWIRE) -- Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the quarter ended June 30, 2026.

Second Quarter 2026 Financial Results

  • Revenue of $7.6 million decreased 23% compared to $9.8 million in the second quarter of 2025.
  • Operating loss was $643,000 compared to $333,000 in the second quarter of 2025.
  • Net loss was $451,000, or $0.05 per diluted share, compared to net income of $15,000, or breakeven per diluted share, in the second quarter of 2025.
  • The number of Active Members1 was 26,000 at June 30, 2026 compared to 26,650 at December 31, 2025 and 29,260 at June 30, 2025.

1Natural Health Trends defines Active Members as those that have placed at least one product order with the Company during the preceding twelve-month period.

Year-to-Date 2026 Financial Results

  • Revenue of $16.8 million decreased 18% compared to $20.6 million in the first six months of 2025.
  • Operating loss was $1.1 million compared to $678,000 in the first six months of 2025.
  • Net loss was $605,000, or $0.06 per diluted share, compared to net income of $137,000, or $0.01 per diluted share, in the first six months of 2025.


Management Commentary

“The operating environment remains challenging. In China, consumers continue to be cautious about spending and investing, while regulatory uncertainty caused some members to pause activities during the quarter. We also identified conduct by certain members that violated the Company's Hong Kong policies, procedures and professional code of conduct. These activities disrupted our business and adversely affected second quarter revenue and operating results. At the same time, the restructuring program implemented late last year has already reduced costs and streamlined our organization, and we expect to realize additional savings in the second half of the year. We are also developing programs and campaigns to more aggressively support our members while continuing to invest in products and technology,” commented Chris Sharng, President of Natural Health Trends Corp.

Mr. Sharng continued, “We're looking forward to celebrating our 25th anniversary in Hong Kong in the third quarter with a full lineup of prizes and rewards that customers can qualify for leading up to and during the event. We expect more than 1,000 attendees from around the world and plan to reconfirm our strategies and commitment at this event.”

Balance Sheet and Cash Flow

  • Net cash used in operating activities was $2.2 million in the first six months of 2026 compared to $5.2 million in the first six months of 2025.
  • Total cash, cash equivalents and marketable securities were $18.6 million at June 30, 2026, down from $28.9 million at December 31, 2025 primarily due to the repurchase of shares of common stock and dividends paid during the first six months of 2026.
  • The Company's Board of Directors has authorized the resumption of share repurchases under its existing stock repurchase program, with $15.9 million remaining available, subject to market conditions and other relevant considerations.


Second
Quarter 2026 Financial Results Conference Call

Management will host a conference call to discuss the second quarter 2026 financial results today, Wednesday, July 29, 2026 at 11:30 a.m. Eastern Time. The conference call details are as follows:

Date:Wednesday, July 29, 2026Time:11:30 a.m. Eastern Time / 8:30 a.m. Pacific TimeDial-in:1-800-330-6730Participant ID:749478


For those unable to participate during the live broadcast, a replay of the call will be available on the Company's Investor Relations website at https://ir.naturalhealthtrendscorp.

About Natural Health Trends Corp.

Natural Health Trends Corp. (NASDAQ: NHTC) is an international direct-selling and e-commerce company operating through its subsidiaries throughout Asia, the Americas, and Europe. The Company markets premium quality personal care products under the NHT Global brand. Additional information can be found on the Company’s website at www.naturalhealthtrendscorp.com.

Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995 -- Forward-looking statements in this press release do not constitute guarantees of future performance. Forward-looking statements in this press release include statements relating to the anticipated effect of restructuring activities, including expected operational efficiencies and cost savings resulting therefrom, statements regarding technology investments, future growth and profitability, and statements relating to future dividends, the declaration and payment of which will be at the sole discretion of the Company's Board of Directors. Such forward-looking statements are subject to risks and uncertainties that could cause the Company’s actual results to differ materially from those anticipated. Such risks and uncertainties include the risks and uncertainties detailed under the caption “Risk Factors” in Natural Health Trends Corp.’s Annual Report on Form 10-K filed on February 20, 2026 with the Securities and Exchange Commission (SEC), as well as in subsequent reports filed this year with the SEC. The Company assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

NATURAL HEALTH TRENDS CORP.
CONSOLIDATED BALANCE SHEETS
(In thousands, except share data)

   June 30, 2026  December 31, 2025   (Unaudited)     ASSETS        Current assets:        Cash and cash equivalents $9,501  $6,813 Marketable securities  9,121   22,060 Inventories  2,049   2,047 Other current assets  3,033   3,274 Total current assets  23,704   34,194 Property and equipment, net  570   153 Operating lease right-of-use assets  2,589   1,869 Deferred tax asset  288   289 Other assets  2,059   1,923 Total assets $29,210  $38,428 LIABILITIES AND STOCKHOLDERS’ EQUITY        Current liabilities:        Accounts payable $964  $555 Accrued commissions  1,741   1,958 Other accrued expenses  1,222   1,438 Deferred revenue  4,205   5,574 Amounts held in eWallets  2,606   2,838 Operating lease liabilities  860   869 Other current liabilities  341   456 Total current liabilities  11,939   13,688 Deferred tax liability  179   180 Operating lease liabilities  1,890   1,131 Total liabilities  14,008   14,999 Stockholders’ equity:        Preferred stock  —   — Common stock  13   13 Additional paid-in capital  85,033   85,033 Accumulated deficit  (38,757)  (36,436)Accumulated other comprehensive loss  (728)  (784)Treasury stock, at cost  (30,359)  (24,397)Total stockholders’ equity  15,202   23,429 Total liabilities and stockholders’ equity $29,210  $38,428 


NATURAL HEALTH TRENDS CORP.
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
(In thousands, except per share data)

   Three Months Ended
June 30,  Six Months Ended
June 30,   2026  2025  2026  2025 Net sales $7,603  $9,813  $16,809  $20,550 Cost of sales  1,882   2,558   4,185   5,390 Gross profit  5,721   7,255   12,624   15,160 Operating expenses:                Commissions expense  3,111   4,012   6,964   8,500 Selling, general and administrative expenses  3,253   3,576   6,777   7,338 Total operating expenses  6,364   7,588   13,741   15,838 Loss from operations  (643)  (333)  (1,117)  (678)Other income, net  190   348   485   813 Income (loss) before income taxes  (453)  15   (632)  135 Income tax benefit  (2)  —   (27)  (2)Net income (loss) $(451) $15  $(605) $137 Net income (loss) per common share:                Basic $(0.05) $0.00  $(0.06) $0.01 Diluted $(0.05) $0.00  $(0.06) $0.01 Weighted average common shares outstanding:                Basic  8,578   11,493   9,356   11,489 Diluted  8,578   11,497   9,356   11,496 


NATURAL HEALTH TRENDS CORP.
CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)

   Six Months Ended June 30,   2026  2025 CASH FLOWS FROM OPERATING ACTIVITIES:        Net income (loss) $(605) $137 Adjustments to reconcile net income (loss) to net cash used in operating activities:        Depreciation and amortization  34   59 Net accretion of marketable securities  (36)  (214)Share-based compensation  —   68 Noncash lease expense  599   573 Deferred income taxes  —   (3)Changes in assets and liabilities:        Inventories  (27)  525 Other current assets  358   402 Other assets  (144)  (334)Accounts payable  376   65 Accrued commissions  (202)  (194)Other accrued expenses  (276)  (110)Deferred revenue  (1,330)  (311)Amounts held in eWallets  (210)  (170)Operating lease liabilities  (585)  (561)Other current liabilities  (113)  (5,083)Net cash used in operating activities  (2,161)  (5,151)CASH FLOWS FROM INVESTING ACTIVITIES:        Purchases of property and equipment  (440)  (20)Purchases of marketable securities  (8,709)  (27,552)Proceeds from maturities of marketable securities  21,566   34,215 Net cash provided by investing activities  12,417   6,643 CASH FLOWS FROM FINANCING ACTIVITIES:        Repurchase of common stock  (5,870)  — Dividends paid  (1,716)  (4,606)Net cash used in financing activities  (7,586)  (4,606)Effect of exchange rates on cash, cash equivalents and restricted cash  17   118 Net increase (decrease) in cash, cash equivalents and restricted cash  2,687   (2,996)CASH, CASH EQUIVALENTS AND RESTRICTED CASH, beginning of period  6,820   13,567 CASH, CASH EQUIVALENTS AND RESTRICTED CASH, end of period $9,507  $10,571 SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND FINANCING ACTIVITIES:        Right-of-use assets obtained in exchange for operating lease liabilities $1,356  $112 Direct costs incurred to repurchase common stock $92  $— 


CONTACT:

Scott Davidson
Senior Vice President and Chief Financial Officer
Natural Health Trends Corp.
Tel (U.S.): 310-541-0888
[email protected]


Risks

  • Continued regulatory uncertainty and cautious consumer spending especially in China impacting sales.
  • Violations of company conduct policies by some members disrupted business operations.
  • Operating losses and declining cash reserves pose ongoing financial risks for sustained growth.

More from Press Releases

Hyperion DeFi Schedules First Quarter Earnings Call for Wednesday, August 12 at 5:00 p.m. ET Jul 29, 2026 SCWorx Receives Nasdaq Hearings Panel Partial Compliance Letter for the Company’s Continued Listing on the Nasdaq Capital Market Jul 29, 2026 The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy Jul 29, 2026 Smith+Nephew’s TESSA™ Spatial Surgery System granted De Novo classification by the FDA sparking a generational leap in Sports Medicine for personalized planning and procedural innovation Jul 29, 2026 Performance Shipping Inc. Reports Financial Results For The Second Quarter and Six Months Ended June 30, 2026 Jul 29, 2026